-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT) Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals (ALXN)
-
-
-
-
-
-
-
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
-
-
-
-
-
-
-
Arcturus Therapeutics Issues Statement Regarding Extraordinary General Meeting of Shareholders
-
-
1,199,233 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


